Table 1 A summary of breast cancer studies located from cBioportal and corresponding frequency of mutations
From: Evaluation of the role of KPNA2 mutations in breast cancer prognosis using bioinformatics datasets
Study | Percent of total cases (Proportion of cases available in dataset) | Frequency |
|---|---|---|
The Metastatic Breast Cancer Project [26] | 15.6%(37/237) | Mutation (1.27%, n = 3) Amplification (14.4%, n = 34) |
Metastatic Breast Cancer (INSERM) [27] | 7.87%(17/216) | Amplification (7.87%, n = 17) |
7.55%(164/2173) | Amplification (7.5%, n = 163) Deep Deletion (0.05%, n = 1) | |
TCGA Pan-cancer Atlas [31] | 6.46%(70/1084) | Mutation (0.55%, n = 6) Amplification (5.9%, n = 64) |